OSER1-DT: A Drug Target / Disease Biomarker (G100505783)

Target Name: OSER1-DT

NCBI ID: G100505783

OSER1-DT

Other Name(s): OSER1 divergent transcript, transcript variant 1 | OSER1 divergent transcript | OSER1-AS1 | OSER1-DT variant 1

OSER1-DT: A Drug Target / Disease Biomarker

OSER1-DT is a protein that is expressed in the brain and is known for its role in the development and progression of neurodegenerative diseases, such as Alzheimer's disease. The protein is derived from the insecticide erionectron, which is toxic to the insecticide-resistant spider, spider mites, and a type of bacteria that are common in the environment.

OSER1-DT has been shown to interact with several other proteins, including the protein huntingtin-2 (HING2), which is a known tumor suppressor protein that has been linked to the development of certain neurological conditions. OSER1-DT has also been shown to interact with the protein heat shock protein (HSP70), which is a protein that is expressed in high levels in the brain and has been linked to the development of neurodegenerative diseases.

In addition to its interactions with other proteins, OSER1-DT has been shown to have unique properties that make it a potential drug target or biomarker. For example, OSER1-DT is a protein that is expressed in the brain and has a high level of expression in regions of the brain that are affected in neurodegenerative diseases. Additionally, OSER1-DT has a relatively low abundance compared to other proteins, which suggests that it is a relatively small molecule that can be easily targeted by drugs.

Furthermore, OSER1-DT has been shown to have a unique localization pattern in the brain. Studies have shown that OSER1-DT is mainly expressed in the frontal and parietal regions of the brain, which are regions that are affected in many neurodegenerative diseases. Additionally, OSER1-DT has a unique distribution pattern in the brain, with higher levels of expression in the prefrontal cortex and lower levels of expression in the basal ganglia.

In conclusion, OSER1-DT is a protein that has unique properties that make it a potential drug target or biomarker. Its interactions with other proteins, including HING2 and HSP70, and its unique localization pattern in the brain suggest that it can be a valuable tool for the development of new treatments for neurodegenerative diseases. Further research is needed to fully understand the role of OSER1-DT in neurodegenerative diseases and to develop effective treatments.

Protein Name: OSER1 Divergent Transcript

The "OSER1-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSER1-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets